Soichiro Yamamura

8.7k total citations
129 papers, 7.2k citations indexed

About

Soichiro Yamamura is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Soichiro Yamamura has authored 129 papers receiving a total of 7.2k indexed citations (citations by other indexed papers that have themselves been cited), including 88 papers in Molecular Biology, 64 papers in Cancer Research and 19 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Soichiro Yamamura's work include Cancer-related molecular mechanisms research (47 papers), MicroRNA in disease regulation (44 papers) and Circular RNAs in diseases (33 papers). Soichiro Yamamura is often cited by papers focused on Cancer-related molecular mechanisms research (47 papers), MicroRNA in disease regulation (44 papers) and Circular RNAs in diseases (33 papers). Soichiro Yamamura collaborates with scholars based in United States, Japan and South Korea. Soichiro Yamamura's co-authors include Rajvir Dahiya, Shahana Majid, Yuichiro Tanaka, Sharanjot Saini, Varahram Shahryari, Guoren Deng, Hiroshi Hirata, Kazuko Handa, Robert G. Roeder and Sen‐itiroh Hakomori and has published in prestigious journals such as Science, Journal of Biological Chemistry and The Journal of Cell Biology.

In The Last Decade

Soichiro Yamamura

126 papers receiving 7.0k citations

Peers

Soichiro Yamamura
Jie Zhou China
Junming Yue United States
Jurre J. Kamphorst United States
Jianjun Shen United States
Jinjun Li China
Soichiro Yamamura
Citations per year, relative to Soichiro Yamamura Soichiro Yamamura (= 1×) peers Nathalie M. Mazure

Countries citing papers authored by Soichiro Yamamura

Since Specialization
Citations

This map shows the geographic impact of Soichiro Yamamura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Soichiro Yamamura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Soichiro Yamamura more than expected).

Fields of papers citing papers by Soichiro Yamamura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Soichiro Yamamura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Soichiro Yamamura. The network helps show where Soichiro Yamamura may publish in the future.

Co-authorship network of co-authors of Soichiro Yamamura

This figure shows the co-authorship network connecting the top 25 collaborators of Soichiro Yamamura. A scholar is included among the top collaborators of Soichiro Yamamura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Soichiro Yamamura. Soichiro Yamamura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kulkarni, Priyanka, Pritha Dasgupta, Yutaka Hashimoto, et al.. (2021). A lncRNA TCL6-miR-155 Interaction Regulates the Src-Akt-EMT Network to Mediate Kidney Cancer Progression and Metastasis. Cancer Research. 81(6). 1500–1512. 42 indexed citations
2.
Hashimoto, Yutaka, Marisa Shiina, Pritha Dasgupta, et al.. (2019). Upregulation of miR-130b Contributes to Risk of Poor Prognosis and Racial Disparity in African-American Prostate Cancer. Cancer Prevention Research. 12(9). 585–598. 22 indexed citations
3.
Dasgupta, Pritha, Priyanka Kulkarni, Shahana Majid, et al.. (2018). MicroRNA-203 Inhibits Long Noncoding RNA HOTAIR and Regulates Tumorigenesis through Epithelial-to-mesenchymal Transition Pathway in Renal Cell Carcinoma. Molecular Cancer Therapeutics. 17(5). 1061–1069. 82 indexed citations
4.
Kulkarni, Priyanka, Pritha Dasgupta, Nadeem S. Bhat, et al.. (2018). Elevated miR-182-5p Associates with Renal Cancer Cell Mitotic Arrest through Diminished MALAT-1 Expression. Molecular Cancer Research. 16(11). 1750–1760. 44 indexed citations
5.
Bhat, Nadeem S., Altaf A. Dar, Sharanjot Saini, et al.. (2017). MicroRNA-720 Regulates E-cadherin–αE-catenin Complex and Promotes Renal Cell Carcinoma. Molecular Cancer Therapeutics. 16(12). 2840–2848. 27 indexed citations
6.
Saini, Sharanjot, Shahana Majid, Varahram Shahryari, et al.. (2014). Regulation of SRC Kinases by microRNA-3607 Located in a Frequently Deleted Locus in Prostate Cancer. Molecular Cancer Therapeutics. 13(7). 1952–1963. 19 indexed citations
7.
Chang, Inik, Shahana Majid, Sharanjot Saini, et al.. (2013). Hrk Mediates 2-Methoxyestradiol–Induced Mitochondrial Apoptotic Signaling in Prostate Cancer Cells. Molecular Cancer Therapeutics. 12(6). 1049–1059. 20 indexed citations
8.
Saini, Sharanjot, Shahana Majid, Varahram Shahryari, et al.. (2012). miRNA-708 Control of CD44+ Prostate Cancer–Initiating Cells. Cancer Research. 72(14). 3618–3630. 103 indexed citations
9.
Majid, Shahana, Altaf A. Dar, Sharanjot Saini, et al.. (2012). miRNA-34b Inhibits Prostate Cancer through Demethylation, Active Chromatin Modifications, and AKT Pathways. Clinical Cancer Research. 19(1). 73–84. 96 indexed citations
10.
Majid, Shahana, Altaf A. Dar, Sharanjot Saini, et al.. (2012). miR-23b Represses Proto-oncogene Src Kinase and Functions as Methylation-Silenced Tumor Suppressor with Diagnostic and Prognostic Significance in Prostate Cancer. Cancer Research. 72(24). 6435–6446. 125 indexed citations
11.
Saini, Sharanjot, Soichiro Yamamura, Shahana Majid, et al.. (2011). MicroRNA-708 Induces Apoptosis and Suppresses Tumorigenicity in Renal Cancer Cells. Cancer Research. 71(19). 6208–6219. 113 indexed citations
12.
Saini, Sharanjot, Sumit Arora, Shahana Majid, et al.. (2011). Curcumin Modulates MicroRNA-203–Mediated Regulation of the Src-Akt Axis in Bladder Cancer. Cancer Prevention Research. 4(10). 1698–1709. 173 indexed citations
13.
Majid, Shahana, Sharanjot Saini, Altaf A. Dar, et al.. (2011). MicroRNA-205 Inhibits Src-Mediated Oncogenic Pathways in Renal Cancer. Cancer Research. 71(7). 2611–2621. 120 indexed citations
14.
Ueno, Koji, Hiroshi Hirata, Shahana Majid, et al.. (2011). Tumor Suppressor MicroRNA-493 Decreases Cell Motility and Migration Ability in Human Bladder Cancer Cells by Downregulating RhoC and FZD4. Molecular Cancer Therapeutics. 11(1). 244–253. 85 indexed citations
15.
Majid, Shahana, Altaf A. Dar, Sharanjot Saini, et al.. (2010). Regulation of Minichromosome Maintenance Gene Family by MicroRNA-1296 and Genistein in Prostate Cancer. Cancer Research. 70(7). 2809–2818. 117 indexed citations
16.
Saini, Sharanjot, Shahana Majid, Soichiro Yamamura, et al.. (2010). Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis. Clinical Cancer Research. 17(16). 5287–5298. 227 indexed citations
17.
Yamamura, Soichiro, Kazumori Kawakami, Hiroshi Hirata, et al.. (2010). Oncogenic Functions of Secreted Frizzled-Related Protein 2 in Human Renal Cancer. Molecular Cancer Therapeutics. 9(6). 1680–1687. 39 indexed citations
18.
Saini, Sharanjot, Jan Liu, Soichiro Yamamura, et al.. (2009). Functional Significance of Secreted Frizzled-Related Protein 1 in Metastatic Renal Cell Carcinomas. Cancer Research. 69(17). 6815–6822. 43 indexed citations
19.
Kawakami, Kazumori, Hiroshi Hirata, Soichiro Yamamura, et al.. (2009). Functional Significance of Wnt Inhibitory Factor-1 Gene in Kidney Cancer. Cancer Research. 69(22). 8603–8610. 62 indexed citations
20.
Hirata, Hiroshi, Yuji Hinoda, Koichi Nakajima, et al.. (2009). Wnt Antagonist Gene DKK2 Is Epigenetically Silenced and Inhibits Renal Cancer Progression through Apoptotic and Cell Cycle Pathways. Clinical Cancer Research. 15(18). 5678–5687. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026